Viz.ai: $1.2B valuation, IPO Readiness 71, Series E. AI-powered clinical decision support platform that detects time-sensitive conditions and coordinates care team. Track live on The IPO Stack.
AI-powered clinical decision support platform that detects time-sensitive conditions and coordinates care teams.
Scores, valuations, and IPO signals for the companies that matter. 5-minute read, every Tuesday.
Top companies most likely to IPO in 2026, ranked by IPO Readiness Score.
Track Viz.ai IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.
Viz.ai has not announced a specific IPO date as of 2026. With an IPO Readiness Score of 71/100, the company shows strong pre-IPO signals. Subscribe to The IPO Stack newsletter for weekly updates.
Viz.ai is valued at $1.2B as of June 2022. This valuation is based on its most recent private funding round tracked by TechStackIPO.
Accredited investors can access Viz.ai shares through secondary market platforms, pre-IPO investment funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace tracks available access options. Note: pre-IPO investments carry higher risk and limited liquidity compared to public market investing.
Viz.ai scores 71/100 (Grade: B) on TechStackIPO's IPO Readiness Index. The score evaluates funding scale, valuation trajectory, funding momentum, stage progression, and company maturity. Scores above 70 indicate strong near-term IPO potential.
Viz.ai has raised $310M in total venture capital and private equity funding, with backing from Tiger Global, Insight Partners, Andreessen Horowitz.
Viz.ai's notable investors include Tiger Global, Insight Partners, Andreessen Horowitz. Full investor details, funding round history, and lead investor breakdowns are available on TechStackIPO.
Viz.ai is a Healthcare Technology company. AI-powered clinical decision support platform that detects time-sensitive conditions and coordinates care teams.